Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second phase Chiba study of mother and child health (C-MACH): Japanese birth cohort study with multiomics analyses.
Koshizaka M, Eguchi A, Takaguchi K, Yamamoto M, Takatani R, Hisada A, Kawanami A, Konno Y, Watanabe M, Tsumura K, Shimatani K, Suzuki N, Mori C, Sakurai K; Chiba Study of Mother and Child Health Group; Chiba Study of Mother and Child Health Group. Koshizaka M, et al. BMJ Open. 2024 Dec 9;14(12):e085682. doi: 10.1136/bmjopen-2024-085682. BMJ Open. 2024. PMID: 39653579 Free PMC article.
Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database.
Ishibashi R, Koshizaka M, Takatsuna Y, Tatsumi T, Maezawa Y, Shiko Y, Inaba Y, Kawasaki Y, Kashiwagi Y, Kawakami E, Yamamoto S, Yokote K. Ishibashi R, et al. Among authors: koshizaka m. J Diabetes Investig. 2024 Sep;15(9):1231-1238. doi: 10.1111/jdi.14253. Epub 2024 Jun 14. J Diabetes Investig. 2024. PMID: 38874094 Free PMC article.
Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database.
Ishibashi R, Inaba Y, Koshizaka M, Takatsuna Y, Tatsumi T, Shiko Y, Kashiwagi Y, Maezawa Y, Kawasaki Y, Kawakami E, Yamamoto S, Yokote K. Ishibashi R, et al. Among authors: koshizaka m. Diabetes Obes Metab. 2024 Apr;26(4):1510-1518. doi: 10.1111/dom.15454. Epub 2024 Jan 19. Diabetes Obes Metab. 2024. PMID: 38240052
A Japanese Case of Familial Hypercholesterolemia with a Protein-truncating Variant in LDLR and a PCSK9 Variant without Significant Atherosclerosis but Showing Remarkable Achilles Tendon Thickening.
Minamizuka T, Kobayashi J, Tada H, Koshizaka M, Maezawa Y, Ono H, Yokote K. Minamizuka T, et al. Among authors: koshizaka m. Intern Med. 2024;63(15):2137-2142. doi: 10.2169/internalmedicine.2726-23. Epub 2024 Aug 1. Intern Med. 2024. PMID: 39085092 Free PMC article.
Recent Trends in WRN Gene Mutation Patterns in Individuals with Werner Syndrome.
Yamaga M, Takemoto M, Takada-Watanabe A, Koizumi N, Kitamoto T, Sakamoto K, Ishikawa T, Koshizaka M, Maezawa Y, Yokote K. Yamaga M, et al. Among authors: koshizaka m. J Am Geriatr Soc. 2017 Aug;65(8):1853-1856. doi: 10.1111/jgs.14906. Epub 2017 Apr 10. J Am Geriatr Soc. 2017. PMID: 28394436
Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study).
Koshizaka M, Ishikawa K, Ishikawa T, Kobayashi K, Takemoto M, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Tatsuno I, Terano T, Hashimoto N, Kuribayashi N, Uchida D, Yokote K; PRIME-V Study Investigators. Koshizaka M, et al. BMJ Open. 2017 May 9;7(5):e015766. doi: 10.1136/bmjopen-2016-015766. BMJ Open. 2017. PMID: 28490565 Free PMC article. Clinical Trial.
Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial.
Minamizuka T, Koshizaka M, Shoji M, Yamaga M, Hayashi A, Ide K, Ide S, Kitamoto T, Sakamoto K, Hattori A, Ishikawa T, Kobayashi J, Maezawa Y, Kobayashi K, Takemoto M, Inagaki M, Endo A, Yokote K. Minamizuka T, et al. Among authors: koshizaka m. Asia Pac J Clin Nutr. 2021 Sep;30(3):424-435. doi: 10.6133/apjcn.202109_30(3).0009. Asia Pac J Clin Nutr. 2021. PMID: 34587702 Free article. Clinical Trial.
79 results